[Federal Register: April 17, 2008 (Volume 73, Number 75)]
[Notices]
[Page 20927]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17ap08-49]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Type-2 Diabetes Prevention in Women With a Recent
History of Gestational Diabetes Mellitus, Potential Extramural Project
(PEP) 2008-R-04.
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 1 p.m.-4 p.m., May 30, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of ``Type-2 Diabetes Prevention in Women
With a Recent History of Gestational Diabetes Mellitus, PEP 2008-R-
04.''
Contact Person for More Information: Linda Shelton, Program
Specialist, Coordinating Center for Health and Information Service,
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498-1194.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: April 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-8326 Filed 4-16-08; 8:45 am]
BILLING CODE 4163-18-P